Season 4 of #ESCTVToday starts in one week!⏳
Now’s a great time to catch up on Season 3. All episodes are open access on ESC365.
Watch a highlight from Milestones: The ‘London Bus Driver’ Trial 👉 https://ow.ly/gQ1K50XXczU
Now’s a great time to catch up on Season 3. All episodes are open access on ESC365.
Watch a highlight from Milestones: The ‘London Bus Driver’ Trial 👉 https://ow.ly/gQ1K50XXczU
January 15, 2026 at 2:03 PM
Season 4 of #ESCTVToday starts in one week!⏳
Now’s a great time to catch up on Season 3. All episodes are open access on ESC365.
Watch a highlight from Milestones: The ‘London Bus Driver’ Trial 👉 https://ow.ly/gQ1K50XXczU
Now’s a great time to catch up on Season 3. All episodes are open access on ESC365.
Watch a highlight from Milestones: The ‘London Bus Driver’ Trial 👉 https://ow.ly/gQ1K50XXczU
What are the incidence and outcomes of atrial-fibrillation, detected by annual screening ECG, in working-age adults?
Don’t miss the summaries of this and many more novel investigations with Carlos Aguiar at Cardiology This Week! #ESCTVToday ow.ly/la2B50XfojS
#AFib #HeartHealth
Don’t miss the summaries of this and many more novel investigations with Carlos Aguiar at Cardiology This Week! #ESCTVToday ow.ly/la2B50XfojS
#AFib #HeartHealth
October 21, 2025 at 12:59 PM
What are the incidence and outcomes of atrial-fibrillation, detected by annual screening ECG, in working-age adults?
Don’t miss the summaries of this and many more novel investigations with Carlos Aguiar at Cardiology This Week! #ESCTVToday ow.ly/la2B50XfojS
#AFib #HeartHealth
Don’t miss the summaries of this and many more novel investigations with Carlos Aguiar at Cardiology This Week! #ESCTVToday ow.ly/la2B50XfojS
#AFib #HeartHealth
How to optimize drug therapy in patients living w/ chronic coronary syndrome?
Robert Storey discusses strategies for the choice of anti-anginal, use of lipid lowering treatment, antiplatelet drugs & beta-blockers. A must-see topic on #ESCTVToday ow.ly/GqXR50X46SN
#ChronicCoronarySyndrome #ESC365
Robert Storey discusses strategies for the choice of anti-anginal, use of lipid lowering treatment, antiplatelet drugs & beta-blockers. A must-see topic on #ESCTVToday ow.ly/GqXR50X46SN
#ChronicCoronarySyndrome #ESC365
September 30, 2025 at 12:29 PM
How to optimize drug therapy in patients living w/ chronic coronary syndrome?
Robert Storey discusses strategies for the choice of anti-anginal, use of lipid lowering treatment, antiplatelet drugs & beta-blockers. A must-see topic on #ESCTVToday ow.ly/GqXR50X46SN
#ChronicCoronarySyndrome #ESC365
Robert Storey discusses strategies for the choice of anti-anginal, use of lipid lowering treatment, antiplatelet drugs & beta-blockers. A must-see topic on #ESCTVToday ow.ly/GqXR50X46SN
#ChronicCoronarySyndrome #ESC365
The latest #ESCTVToday episodes are FREE to watch - only until 25 September! 👉 ow.ly/k2Fc50WXt5J
Hot topics: smartwatch ECG, Afib, stroke, obesity, cardiomyopathy, ICDs, digital health & more.
✨ New episode drops Thu 25 Sept!
#cardiology #ESCTV #CVD
Hot topics: smartwatch ECG, Afib, stroke, obesity, cardiomyopathy, ICDs, digital health & more.
✨ New episode drops Thu 25 Sept!
#cardiology #ESCTV #CVD
September 16, 2025 at 12:50 PM
The latest #ESCTVToday episodes are FREE to watch - only until 25 September! 👉 ow.ly/k2Fc50WXt5J
Hot topics: smartwatch ECG, Afib, stroke, obesity, cardiomyopathy, ICDs, digital health & more.
✨ New episode drops Thu 25 Sept!
#cardiology #ESCTV #CVD
Hot topics: smartwatch ECG, Afib, stroke, obesity, cardiomyopathy, ICDs, digital health & more.
✨ New episode drops Thu 25 Sept!
#cardiology #ESCTV #CVD
Want a preview of the day's sessions and events in less than 15 minutes?
Catch the ESC TV Morning Show every day at 08:00 on the ESC TV Stage (Hall 6). bit.ly/45I3gYY
#ESCCongress #ESCTV #ESCTVToday
Catch the ESC TV Morning Show every day at 08:00 on the ESC TV Stage (Hall 6). bit.ly/45I3gYY
#ESCCongress #ESCTV #ESCTVToday
August 29, 2025 at 1:00 PM
Want a preview of the day's sessions and events in less than 15 minutes?
Catch the ESC TV Morning Show every day at 08:00 on the ESC TV Stage (Hall 6). bit.ly/45I3gYY
#ESCCongress #ESCTV #ESCTVToday
Catch the ESC TV Morning Show every day at 08:00 on the ESC TV Stage (Hall 6). bit.ly/45I3gYY
#ESCCongress #ESCTV #ESCTVToday
#ESCTVToday: Can smartwatches spot #AFib as well as ECGs? Tim Chico explains the science, benefits & false alarms 👉 bit.ly/474P8dv
🎥 Season 3 is free until 25 Sept, 16:00 CEST, right before Season 4 drops!
#WearableTech #HeartHealth #DigitalHealth
🎥 Season 3 is free until 25 Sept, 16:00 CEST, right before Season 4 drops!
#WearableTech #HeartHealth #DigitalHealth
August 22, 2025 at 8:40 AM
#ESCTVToday: Can smartwatches spot #AFib as well as ECGs? Tim Chico explains the science, benefits & false alarms 👉 bit.ly/474P8dv
🎥 Season 3 is free until 25 Sept, 16:00 CEST, right before Season 4 drops!
#WearableTech #HeartHealth #DigitalHealth
🎥 Season 3 is free until 25 Sept, 16:00 CEST, right before Season 4 drops!
#WearableTech #HeartHealth #DigitalHealth
Catch the latest on #ESCTVToday 👉 The 1994 Lyon Diet Heart Study showed how a Mediterranean diet after MI reshaped nutrition guidelines. 🍇🥗
📺 Season 3 is FREE until 25 Sept, 16:00 CES, just before S4 launches! ow.ly/8gh850WHmXf
#Cardiology #HeartHealth #MediterraneanDiet
📺 Season 3 is FREE until 25 Sept, 16:00 CES, just before S4 launches! ow.ly/8gh850WHmXf
#Cardiology #HeartHealth #MediterraneanDiet
August 18, 2025 at 8:07 AM
Catch the latest on #ESCTVToday 👉 The 1994 Lyon Diet Heart Study showed how a Mediterranean diet after MI reshaped nutrition guidelines. 🍇🥗
📺 Season 3 is FREE until 25 Sept, 16:00 CES, just before S4 launches! ow.ly/8gh850WHmXf
#Cardiology #HeartHealth #MediterraneanDiet
📺 Season 3 is FREE until 25 Sept, 16:00 CES, just before S4 launches! ow.ly/8gh850WHmXf
#Cardiology #HeartHealth #MediterraneanDiet
#ESCTVToday - Does cooling the body after resuscitated cardiac arrest truly positively influence outcome?
Christian Hassager examines how temperature management became the current standard of care, shares the latest evidence, & provides advice for today´s clinical practice bit.ly/3UVqxjN
Christian Hassager examines how temperature management became the current standard of care, shares the latest evidence, & provides advice for today´s clinical practice bit.ly/3UVqxjN
August 12, 2025 at 12:44 PM
#ESCTVToday - Does cooling the body after resuscitated cardiac arrest truly positively influence outcome?
Christian Hassager examines how temperature management became the current standard of care, shares the latest evidence, & provides advice for today´s clinical practice bit.ly/3UVqxjN
Christian Hassager examines how temperature management became the current standard of care, shares the latest evidence, & provides advice for today´s clinical practice bit.ly/3UVqxjN
Catch the latest on #ESCTVToday 👉 Tricuspid regurgitation in heart failure, management of NSTEMI in the elderly, and stroke risk in atrial fibrillation - find out about these trials and more in 'Cardiology this Week' bit.ly/40X9rFX
#obesity #Afib #stroke #Tricuspidregurgitation
#obesity #Afib #stroke #Tricuspidregurgitation
August 8, 2025 at 12:31 PM
Catch the latest on #ESCTVToday 👉 Tricuspid regurgitation in heart failure, management of NSTEMI in the elderly, and stroke risk in atrial fibrillation - find out about these trials and more in 'Cardiology this Week' bit.ly/40X9rFX
#obesity #Afib #stroke #Tricuspidregurgitation
#obesity #Afib #stroke #Tricuspidregurgitation
#ESCTVToday - Update on ICD indications in primary prevention: who is truly at risk?
Gerhard Hindricks discusses key insights from the DANISH trial, the role of LGE in risk stratification, high-risk genes in DCM, personalised ICD indications, the ongoing PROFID-EHRA trial, & more ow.ly/naqg50WuyNj
Gerhard Hindricks discusses key insights from the DANISH trial, the role of LGE in risk stratification, high-risk genes in DCM, personalised ICD indications, the ongoing PROFID-EHRA trial, & more ow.ly/naqg50WuyNj
July 25, 2025 at 12:17 PM
#ESCTVToday - Update on ICD indications in primary prevention: who is truly at risk?
Gerhard Hindricks discusses key insights from the DANISH trial, the role of LGE in risk stratification, high-risk genes in DCM, personalised ICD indications, the ongoing PROFID-EHRA trial, & more ow.ly/naqg50WuyNj
Gerhard Hindricks discusses key insights from the DANISH trial, the role of LGE in risk stratification, high-risk genes in DCM, personalised ICD indications, the ongoing PROFID-EHRA trial, & more ow.ly/naqg50WuyNj
Catch the latest on #ESCTVToday 👉
Which of the following are specific treatments for ATTR-CM:
a)TTR stabilization and TTR gene silencers
b)Beta-Blockers and Amiodarone
c)SGLT2 inhibitors and Spironolactone
d)Vitamin A
🔗https://ow.ly/hHby50WrNYw
#cardiacamyloidosis
Which of the following are specific treatments for ATTR-CM:
a)TTR stabilization and TTR gene silencers
b)Beta-Blockers and Amiodarone
c)SGLT2 inhibitors and Spironolactone
d)Vitamin A
🔗https://ow.ly/hHby50WrNYw
#cardiacamyloidosis
July 21, 2025 at 8:08 AM
Catch the latest on #ESCTVToday 👉
Which of the following are specific treatments for ATTR-CM:
a)TTR stabilization and TTR gene silencers
b)Beta-Blockers and Amiodarone
c)SGLT2 inhibitors and Spironolactone
d)Vitamin A
🔗https://ow.ly/hHby50WrNYw
#cardiacamyloidosis
Which of the following are specific treatments for ATTR-CM:
a)TTR stabilization and TTR gene silencers
b)Beta-Blockers and Amiodarone
c)SGLT2 inhibitors and Spironolactone
d)Vitamin A
🔗https://ow.ly/hHby50WrNYw
#cardiacamyloidosis
Featured on #ESCTVToday - In 2000, Raymond Kim and his team showed that late gadolinium enhancement on cardiac MRI could predict myocardial recovery after revascularisation — a discovery that transformed cardiac imaging. ow.ly/bV2950WqnF8
July 16, 2025 at 8:16 AM
Featured on #ESCTVToday - In 2000, Raymond Kim and his team showed that late gadolinium enhancement on cardiac MRI could predict myocardial recovery after revascularisation — a discovery that transformed cardiac imaging. ow.ly/bV2950WqnF8
#ESCTVToday - Konstantinos Koskinas reviews key points for lipid testing in cardiovascular risk assessment — including fasting status, high triglycerides, and diabetes. He also explains how to interpret results after acute events and when to consider ApoB, non-HDL-C & Lp(a). ow.ly/W4wv50WnKEr
July 11, 2025 at 1:47 PM
#ESCTVToday - Konstantinos Koskinas reviews key points for lipid testing in cardiovascular risk assessment — including fasting status, high triglycerides, and diabetes. He also explains how to interpret results after acute events and when to consider ApoB, non-HDL-C & Lp(a). ow.ly/W4wv50WnKEr
#ESCTVToday - How does 'Big Data' impact cardiology?
Karim Lekadir explores current applications, future opportunities & the importance of addressing bias for inclusive tools. ow.ly/N5uV50Wlsww
#DigitalHealth #BigData
Karim Lekadir explores current applications, future opportunities & the importance of addressing bias for inclusive tools. ow.ly/N5uV50Wlsww
#DigitalHealth #BigData
July 7, 2025 at 10:17 AM
#ESCTVToday - How does 'Big Data' impact cardiology?
Karim Lekadir explores current applications, future opportunities & the importance of addressing bias for inclusive tools. ow.ly/N5uV50Wlsww
#DigitalHealth #BigData
Karim Lekadir explores current applications, future opportunities & the importance of addressing bias for inclusive tools. ow.ly/N5uV50Wlsww
#DigitalHealth #BigData
#ESCTVToday - The relevance of heart failure with improved ejection fraction, atrial amyloidosis in patients with atrial fibrillation, prognostic implications of microvascular obstruction following STEMI - these trials and more in 'Cardiology this Week' bit.ly/4n5bTDu
#Afib #CVD
#Afib #CVD
June 17, 2025 at 9:46 AM
#ESCTVToday - The relevance of heart failure with improved ejection fraction, atrial amyloidosis in patients with atrial fibrillation, prognostic implications of microvascular obstruction following STEMI - these trials and more in 'Cardiology this Week' bit.ly/4n5bTDu
#Afib #CVD
#Afib #CVD
#ESCTVToday – What are the LDL cholesterol targets in high-risk and very high-risk patients? J. Wouter makes a point for early combination therapy, rapid evaluation and escalation, and aiming for ultra-low LDL levels in selected individuals, including so-called "frequent flyers". ow.ly/hIex50W5zUN
June 12, 2025 at 8:50 AM
#ESCTVToday – What are the LDL cholesterol targets in high-risk and very high-risk patients? J. Wouter makes a point for early combination therapy, rapid evaluation and escalation, and aiming for ultra-low LDL levels in selected individuals, including so-called "frequent flyers". ow.ly/hIex50W5zUN
This week on #ESCTVToday - Implantation of a "coronary sinus reducer" is an interventional approach to relieve refractory angina by narrowing the coronary venous system.
June 10, 2025 at 11:58 AM
This week on #ESCTVToday - Implantation of a "coronary sinus reducer" is an interventional approach to relieve refractory angina by narrowing the coronary venous system.
Catch the latest #ESCTVToday 👉 bit.ly/3Zg5P0R
When randomised controlled trials aren’t feasible, quasi-experimental designs offer practical tools to assess interventions in real-world settings. From regression discontinuity to interrupted time series, these methods provide valuable insights.
When randomised controlled trials aren’t feasible, quasi-experimental designs offer practical tools to assess interventions in real-world settings. From regression discontinuity to interrupted time series, these methods provide valuable insights.
June 3, 2025 at 12:22 PM
Catch the latest #ESCTVToday 👉 bit.ly/3Zg5P0R
When randomised controlled trials aren’t feasible, quasi-experimental designs offer practical tools to assess interventions in real-world settings. From regression discontinuity to interrupted time series, these methods provide valuable insights.
When randomised controlled trials aren’t feasible, quasi-experimental designs offer practical tools to assess interventions in real-world settings. From regression discontinuity to interrupted time series, these methods provide valuable insights.
How can #CMR help diagnose myocarditis, cardiomyopathies, & heart issues related to long #COVID? bit.ly/4mypy5F
In this #ESCTVToday episode, Steffen Petersen explains how #CMR accurately identifies these conditions, guides treatment, and differentiates between different types of #cardiomyopathy
In this #ESCTVToday episode, Steffen Petersen explains how #CMR accurately identifies these conditions, guides treatment, and differentiates between different types of #cardiomyopathy
May 28, 2025 at 9:09 AM
How can #CMR help diagnose myocarditis, cardiomyopathies, & heart issues related to long #COVID? bit.ly/4mypy5F
In this #ESCTVToday episode, Steffen Petersen explains how #CMR accurately identifies these conditions, guides treatment, and differentiates between different types of #cardiomyopathy
In this #ESCTVToday episode, Steffen Petersen explains how #CMR accurately identifies these conditions, guides treatment, and differentiates between different types of #cardiomyopathy
Catch the latest #ESCTVToday with Carlos Aguiar
Which strategy is safer for patients requiring TAVI and high-risk PCI? bit.ly/4dpgmfQ
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#TAVI #CVD #PCI
Which strategy is safer for patients requiring TAVI and high-risk PCI? bit.ly/4dpgmfQ
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#TAVI #CVD #PCI
May 21, 2025 at 8:33 AM
Catch the latest #ESCTVToday with Carlos Aguiar
Which strategy is safer for patients requiring TAVI and high-risk PCI? bit.ly/4dpgmfQ
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#TAVI #CVD #PCI
Which strategy is safer for patients requiring TAVI and high-risk PCI? bit.ly/4dpgmfQ
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#TAVI #CVD #PCI
Does the addition of ezetimibe to high-intensity statin therapy early after MI associates with improved MACE?
Carlos Aguiar discusses critical data of the SWEDEHEART Registry on Cardiology This Week #ESCTVToday bit.ly/43hdQVA
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
Carlos Aguiar discusses critical data of the SWEDEHEART Registry on Cardiology This Week #ESCTVToday bit.ly/43hdQVA
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
May 6, 2025 at 8:23 AM
Does the addition of ezetimibe to high-intensity statin therapy early after MI associates with improved MACE?
Carlos Aguiar discusses critical data of the SWEDEHEART Registry on Cardiology This Week #ESCTVToday bit.ly/43hdQVA
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
Carlos Aguiar discusses critical data of the SWEDEHEART Registry on Cardiology This Week #ESCTVToday bit.ly/43hdQVA
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
Should we treat hypertension any differently in the elderly & very old pts?
Gianfranco Parati discusses tips & tricks to balance of CV protection w/ side effect avoidance & much more on #ESCTVToday bit.ly/3GCUD7U
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#hypertension #CVD
Gianfranco Parati discusses tips & tricks to balance of CV protection w/ side effect avoidance & much more on #ESCTVToday bit.ly/3GCUD7U
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#hypertension #CVD
May 2, 2025 at 12:33 PM
Should we treat hypertension any differently in the elderly & very old pts?
Gianfranco Parati discusses tips & tricks to balance of CV protection w/ side effect avoidance & much more on #ESCTVToday bit.ly/3GCUD7U
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#hypertension #CVD
Gianfranco Parati discusses tips & tricks to balance of CV protection w/ side effect avoidance & much more on #ESCTVToday bit.ly/3GCUD7U
Sign up for reminders so you Never Miss a Beat ow.ly/wqyK50VFfnx
#hypertension #CVD
This week on #ESCTVToday - A digital twin is a personalised virtual model of the heart that combines individual patient data with advanced simulations to predict treatment outcomes. For some diseases, the digital twin is already a clinical reality.
April 29, 2025 at 1:09 PM
This week on #ESCTVToday - A digital twin is a personalised virtual model of the heart that combines individual patient data with advanced simulations to predict treatment outcomes. For some diseases, the digital twin is already a clinical reality.
#ESCTVToday – The risk of occasional smoking, Z-drugs and cardiovascular outcomes in heart failure, and the role of coronary plaque in risk stratification – explore these trials and more in 'Cardiology This Week'. 👉 bit.ly/3RdPLbz
Sign up for reminders so you Never Miss a Beat👉 bit.ly/4eqyaac
Sign up for reminders so you Never Miss a Beat👉 bit.ly/4eqyaac
April 22, 2025 at 9:32 AM
#ESCTVToday – The risk of occasional smoking, Z-drugs and cardiovascular outcomes in heart failure, and the role of coronary plaque in risk stratification – explore these trials and more in 'Cardiology This Week'. 👉 bit.ly/3RdPLbz
Sign up for reminders so you Never Miss a Beat👉 bit.ly/4eqyaac
Sign up for reminders so you Never Miss a Beat👉 bit.ly/4eqyaac
New on #ESCTVToday! What are the benefits of pacing the left bundle branch area in patients with and without heart failure or left bundle branch block? Haran Burri explores the most recent data, sharing personal insight and the newest advice from the 2025 ESC consensus document. bit.ly/3RdPLbz
April 18, 2025 at 12:22 PM
New on #ESCTVToday! What are the benefits of pacing the left bundle branch area in patients with and without heart failure or left bundle branch block? Haran Burri explores the most recent data, sharing personal insight and the newest advice from the 2025 ESC consensus document. bit.ly/3RdPLbz